amgen maritide glp-1 drug comparison A GIPR antagonist conjugated to analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Beyond GLP-1: the next wave
Description
Immunology drugs are still profitable
Wondering what you can eat while on GLP-1 meds
Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why GLP-1 users stop taking the drug.
Support weight loss with Wisps GLP-1 supplement
CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.
Learn how to use GLP-1 medications safely and effectively
